{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:30:15Z","timestamp":1790116215220,"version":"4.0.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"DOI":"10.7759\/cureus.87283","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T09:27:37Z","timestamp":1751621257000},"source":"Crossref","is-referenced-by-count":7,"title":["Obesity Epidemic and Its Impact on Female Fertility: Current Understanding and Future Directions"],"prefix":"10.7759","author":[{"given":"Radhika","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Garcia de Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Chemerinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhvani","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/159281","article-title":"Obesity and severe obesity prevalence in adults: United States, August 2021-August 2023","volume":"2024","author":"Emmerich SD","year":"2024","unstructured":"Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and severe obesity prevalence in adults: United States, August 2021-August 2023. NCHS Data Brief. 2024, 2024:10. 10.15620\/cdc\/159281","journal-title":"NCHS Data Brief"},{"key":"ref2","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","year":"2000","unstructured":"Obesity. preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894:1-253.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref3","article-title":"Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities","author":"National Center for Health Statistics (US)","year":"2016","unstructured":"National Center for Health Statistics (US). Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. National Center for Health Statistics (US), Hyattsville (MD); 2016."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41432","article-title":"Trends in obesity-related mortality and racial disparities","volume":"15","author":"Okobi OE","year":"2023","unstructured":"Okobi OE, Beeko PK, Nikravesh E, et al.. Trends in obesity-related mortality and racial disparities. Cureus. 2023, 15:e41432. 10.7759\/cureus.41432","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2011.01.100076","article-title":"Obesity and women's health: an evidence-based review","volume":"24","author":"Kulie T","year":"2011","unstructured":"Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S. Obesity and women's health: an evidence-based review. J Am Board Fam Med. 2011, 24:75-85. 10.3122\/jabfm.2011.01.100076","journal-title":"J Am Board Fam Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295360","article-title":"Association between waist circumference and female infertility in the United States","volume":"18","author":"Ke J","year":"2023","unstructured":"Ke J, Feng Y, Chen Z. Association between waist circumference and female infertility in the United States. PLoS One. 2023, 18:e0295360. 10.1371\/journal.pone.0295360","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16397-x","article-title":"Association between metabolic healthy obesity and female infertility: the national health and nutrition examination survey, 2013-2020","volume":"23","author":"Tang J","year":"2023","unstructured":"Tang J, Xu Y, Wang Z, et al.. Association between metabolic healthy obesity and female infertility: the national health and nutrition examination survey, 2013-2020. BMC Public Health. 2023, 23:1524. 10.1186\/s12889-023-16397-x","journal-title":"BMC Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.04.036","article-title":"The impact of obesity on reproductive health and metabolism in reproductive-age females","volume":"122","author":"Schon SB","year":"2024","unstructured":"Schon SB, Cabre HE, Redman LM. The impact of obesity on reproductive health and metabolism in reproductive-age females. Fertil Steril. 2024, 122:194-203. 10.1016\/j.fertnstert.2024.04.036","journal-title":"Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v93i4.13466","article-title":"Female obesity and infertility: outcomes and regulatory guidance","volume":"93","author":"Marinelli S","year":"2022","unstructured":"Marinelli S, Napoletano G, Straccamore M, Basile G. Female obesity and infertility: outcomes and regulatory guidance. Acta Biomed. 2022, 93:e2022278. 10.23750\/abm.v93i4.13466","journal-title":"Acta Biomed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.12.032","article-title":"Female obesity impairs in vitro fertilization outcome without affecting embryo quality","volume":"93","author":"Bellver J","year":"2010","unstructured":"Bellver J, Ayll\u00f3n Y, Ferrando M, et al.. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010, 93:447-54. 10.1016\/j.fertnstert.2008.12.032","journal-title":"Fertil Steril"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.10.015","article-title":"Effect of class III and class IV obesity on oocyte retrieval complications and outcomes","volume":"111","author":"Romanski PA","year":"2019","unstructured":"Romanski PA, Farland LV, Tsen LC, Ginsburg ES, Lewis EI. Effect of class III and class IV obesity on oocyte retrieval complications and outcomes. Fertil Steril. 2019, 111:294-301. 10.1016\/j.fertnstert.2018.10.015","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity's impact","volume":"107","author":"Broughton DE","year":"2017","unstructured":"Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017, 107:840-7. 10.1016\/j.fertnstert.2017.01.017","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.026","article-title":"Impact of male obesity on infertility: a critical review of the current literature","volume":"90","author":"Hammoud AO","year":"2008","unstructured":"Hammoud AO, Gibson M, Peterson CM, Meikle AW, Carrell DT. Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril. 2008, 90:897-904. 10.1016\/j.fertnstert.2008.08.026","journal-title":"Fertil Steril"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2020.05.011","article-title":"The association of euploid miscarriage with obesity","volume":"1","author":"Lee JC","year":"2020","unstructured":"Lee JC, Bernardi LA, Boots CE. The association of euploid miscarriage with obesity. F S Rep. 2020, 1:142-8. 10.1016\/j.xfre.2020.05.011","journal-title":"F S Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.02.114","article-title":"Adverse effects of female obesity and interaction with race on reproductive potential","volume":"107","author":"Luke B","year":"2017","unstructured":"Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017, 107:868-77. 10.1016\/j.fertnstert.2017.02.114","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k09e-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi R","year":"2009","unstructured":"Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J. 2009, 56:729-37. 10.1507\/endocrj.k09e-185","journal-title":"Endocr J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1693","article-title":"Leptin indirectly regulates gonadotropin-releasing hormone neuronal function","volume":"150","author":"Quennell JH","year":"2009","unstructured":"Quennell JH, Mulligan AC, Tups A, et al.. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology. 2009, 150:2805-12. 10.1210\/en.2008-1693","journal-title":"Endocrinology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-0096","article-title":"Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis","volume":"152","author":"Louis GW","year":"2011","unstructured":"Louis GW, Greenwald-Yarnell M, Phillips R, Coolen LM, Lehman MN, Myers MG Jr. Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis. Endocrinology. 2011, 152:2302-10. 10.1210\/en.2011-0096","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1646-9","article-title":"Downregulation of leptin receptor and kisspeptin\/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity","volume":"62","author":"Zhai L","year":"2018","unstructured":"Zhai L, Zhao J, Zhu Y, Liu Q, Niu W, Liu C, Wang Y. Downregulation of leptin receptor and kisspeptin\/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity. Endocrine. 2018, 62:195-206. 10.1007\/s12020-018-1646-9","journal-title":"Endocrine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1406","article-title":"Dietary-induced obesity and hypothalamic infertility in female DBA\/2J mice","volume":"145","author":"Tortoriello DV","year":"2004","unstructured":"Tortoriello DV, McMinn J, Chua SC. Dietary-induced obesity and hypothalamic infertility in female DBA\/2J mice. Endocrinology. 2004, 145:1238-47. 10.1210\/en.2003-1406","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-018-0366-6","article-title":"Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis","volume":"16","author":"Goldsammler M","year":"2018","unstructured":"Goldsammler M, Merhi Z, Buyuk E. Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reprod Biol Endocrinol. 2018, 16:45. 10.1186\/s12958-018-0366-6","journal-title":"Reprod Biol Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.043","article-title":"Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research","volume":"203","author":"Jungheim ES","year":"2010","unstructured":"Jungheim ES, Moley KH. Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol. 2010, 203:525-30. 10.1016\/j.ajog.2010.06.043","journal-title":"Am J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020529","article-title":"Effect of inflammation on female gonadotropin-releasing hormone (GnRH) neurons: mechanisms and consequences","volume":"21","author":"Barab\u00e1s K","year":"2020","unstructured":"Barab\u00e1s K, Szab\u00f3-Meleg E, \u00c1brah\u00e1m IM. Effect of inflammation on female gonadotropin-releasing hormone (GnRH) neurons: mechanisms and consequences. Int J Mol Sci. 2020, 21:529. 10.3390\/ijms21020529","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1946","article-title":"Estradiol priming improves gonadotrope sensitivity and pro-inflammatory cytokines in obese women","volume":"100","author":"Al-Safi ZA","year":"2015","unstructured":"Al-Safi ZA, Liu H, Carlson NE, et al.. Estradiol priming improves gonadotrope sensitivity and pro-inflammatory cytokines in obese women. J Clin Endocrinol Metab. 2015, 100:4372-81. 10.1210\/jc.2015-1946","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.11.062","article-title":"Women, weight, and fertility: the effect of body mass index on the outcome of superovulation\/intrauterine insemination cycles","volume":"95","author":"Souter I","year":"2011","unstructured":"Souter I, Baltagi LM, Kuleta D, Meeker JD, Petrozza JC. Women, weight, and fertility: the effect of body mass index on the outcome of superovulation\/intrauterine insemination cycles. Fertil Steril. 2011, 95:1042-7. 10.1016\/j.fertnstert.2010.11.062","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00686","article-title":"Insulin reduces reaction of follicular granulosa cells to FSH stimulation in women with obesity-related infertility during IVF","volume":"104","author":"Xu P","year":"2019","unstructured":"Xu P, Huang BY, Zhan JH, et al.. Insulin reduces reaction of follicular granulosa cells to FSH stimulation in women with obesity-related infertility during IVF. J Clin Endocrinol Metab. 2019, 104:2547-60. 10.1210\/jc.2018-00686","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0098","article-title":"Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring","volume":"151","author":"Jungheim ES","year":"2010","unstructured":"Jungheim ES, Schoeller EL, Marquard KL, Louden ED, Schaffer JE, Moley KH. Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring. Endocrinology. 2010, 151:4039-46. 10.1210\/en.2010-0098","journal-title":"Endocrinology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049217","article-title":"High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation\/brain defects","volume":"7","author":"Luzzo KM","year":"2012","unstructured":"Luzzo KM, Wang Q, Purcell SH, et al.. High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation\/brain defects. PLoS One. 2012, 7:e49217. 10.1371\/journal.pone.0049217","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des308","article-title":"The association between severe obesity and characteristics of failed fertilized oocytes","volume":"27","author":"Machtinger R","year":"2012","unstructured":"Machtinger R, Combelles CM, Missmer SA, Correia KF, Fox JH, Racowsky C. The association between severe obesity and characteristics of failed fertilized oocytes. Hum Reprod. 2012, 27:3198-207. 10.1093\/humrep\/des308","journal-title":"Hum Reprod"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1071\/RD14251","article-title":"Adverse effects of obesity and\/or high-fat diet on oocyte quality and metabolism are not reversible with resumption of regular diet in mice","volume":"27","author":"Reynolds KA","year":"2015","unstructured":"Reynolds KA, Boudoures AL, Chi MM, Wang Q, Moley KH. Adverse effects of obesity and\/or high-fat diet on oocyte quality and metabolism are not reversible with resumption of regular diet in mice. Reprod Fertil Dev. 2015, 27:716-24. 10.1071\/RD14251","journal-title":"Reprod Fertil Dev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0551","article-title":"High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates","volume":"151","author":"Wu LL","year":"2010","unstructured":"Wu LL, Dunning KR, Yang X, Russell DL, Lane M, Norman RJ, Robker RL. High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates. Endocrinology. 2010, 151:5438-45. 10.1210\/en.2010-0551","journal-title":"Endocrinology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-107617","article-title":"High leptin level attenuates embryo development in overweight\/obese infertile women by inhibiting proliferation and promotes apoptosis in granule cell","volume":"49","author":"Lin XH","year":"2017","unstructured":"Lin XH, Wang H, Wu DD, Ullah K, Yu TT, Ur Rahman T, Huang HF. High leptin level attenuates embryo development in overweight\/obese infertile women by inhibiting proliferation and promotes apoptosis in granule cell. Horm Metab Res. 2017, 49:534-41. 10.1055\/s-0043-107617","journal-title":"Horm Metab Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.01.154","article-title":"Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization","volume":"95","author":"Jungheim ES","year":"2011","unstructured":"Jungheim ES, Macones GA, Odem RR, Patterson BW, Lanzendorf SE, Ratts VS, Moley KH. Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization. Fertil Steril. 2011, 95:1970-4. 10.1016\/j.fertnstert.2011.01.154","journal-title":"Fertil Steril"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det072","article-title":"Leptin suppresses anti-Mullerian hormone gene expression through the JAK2\/STAT3 pathway in luteinized granulosa cells of women undergoing IVF","volume":"28","author":"Merhi Z","year":"2013","unstructured":"Merhi Z, Buyuk E, Berger DS, Zapantis A, Israel DD, Chua S Jr, Jindal S. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2\/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Hum Reprod. 2013, 28:1661-9. 10.1093\/humrep\/det072","journal-title":"Hum Reprod"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.07.001","article-title":"The follicular fluid adipocytokine milieu could serve as a prediction tool for fertility treatment outcomes","volume":"43","author":"Wyse BA","year":"2021","unstructured":"Wyse BA, Fuchs Weizman N, Defer M, Montbriand J, Szaraz P, Librach C. The follicular fluid adipocytokine milieu could serve as a prediction tool for fertility treatment outcomes. Reprod Biomed Online. 2021, 43:738-46. 10.1016\/j.rbmo.2021.07.001","journal-title":"Reprod Biomed Online"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-2080","article-title":"Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice","volume":"157","author":"Cheng L","year":"2016","unstructured":"Cheng L, Shi H, Jin Y, et al.. Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology. 2016, 157:4875-87. 10.1210\/en.2015-2080","journal-title":"Endocrinology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.08.001","article-title":"Yen & Jaffe's reproductive endocrinology: physiology, pathophysiology, and clinical management","volume":"92","author":"Strauss JF","year":"2009","unstructured":"Strauss JF, Barbieri RL, Dokras A, Williams CJ, Williams Z, Yen SSC. Yen & Jaffe's reproductive endocrinology: physiology, pathophysiology, and clinical management. Fertil Steril. 2009, 92:2125. 10.1016\/j.fertnstert.2009.08.001","journal-title":"Fertil Steril"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776420","article-title":"Obesity and in vitro fertilization","volume":"41","author":"Ferrell EL","year":"2023","unstructured":"Ferrell EL, Choudhry AA, Schon SB. Obesity and in vitro fertilization. Semin Reprod Med. 2023, 41:87-96. 10.1055\/s-0043-1776420","journal-title":"Semin Reprod Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.08.018","article-title":"Obesity and reproduction: a committee opinion","volume":"116","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2021","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril. 2021, 116:1266-85. 10.1016\/j.fertnstert.2021.08.018","journal-title":"Fertil Steril"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:16:1:21","article-title":"Leptin upregulates beta3-integrin expression and interleukin-1beta, upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures","volume":"16","author":"Gonzalez RR","year":"2001","unstructured":"Gonzalez RR, Leavis P. Leptin upregulates beta3-integrin expression and interleukin-1beta, upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures. Endocrine. 2001, 16:21-8. 10.1385\/ENDO:16:1:21","journal-title":"Endocrine"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1570032","article-title":"A focused look at obesity and the preimplantation trophoblast","volume":"34","author":"Broughton DE","year":"2016","unstructured":"Broughton DE, Jungheim ES. A focused look at obesity and the preimplantation trophoblast. Semin Reprod Med. 2016, 34:5-10. 10.1055\/s-0035-1570032","journal-title":"Semin Reprod Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.10.017","article-title":"The impact of obesity and metabolic health on male fertility: a systematic review","volume":"120","author":"Service CA","year":"2023","unstructured":"Service CA, Puri D, Al Azzawi S, Hsieh TC, Patel DP. The impact of obesity and metabolic health on male fertility: a systematic review. Fertil Steril. 2023, 120:1098-111. 10.1016\/j.fertnstert.2023.10.017","journal-title":"Fertil Steril"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfnr.2021.09.002","article-title":"Assisted reproductive technology outcomes in obese and diabetic men: lighting the darkness","volume":"2","author":"Puga Molina LC","year":"2021","unstructured":"Puga Molina LC, Oliveira PF, Alves MG, Martin-Hidalgo D. Assisted reproductive technology outcomes in obese and diabetic men: lighting the darkness. F&S Reviews. 2021, 2:317-29. 10.1016\/j.xfnr.2021.09.002","journal-title":"F&S Reviews"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2023.05.003","article-title":"Association between obesity and fecundity in patients undergoing intrauterine insemination","volume":"4","author":"Craig LB","year":"2023","unstructured":"Craig LB, Jarshaw CL, Hansen KR, Peck JD. Association between obesity and fecundity in patients undergoing intrauterine insemination. F S Rep. 2023, 4:270-8. 10.1016\/j.xfre.2023.05.003","journal-title":"F S Rep"},{"key":"ref45","article-title":"Pregnancy predictors after intrauterine insemination: analysis of 3012 cycles in 1201 couples","volume":"13","author":"Soria M","year":"2012","unstructured":"Soria M, Pradillo G, Garc\u00eda J, Ram\u00f3n P, Castillo A, Jordana C, Paricio P. Pregnancy predictors after intrauterine insemination: analysis of 3012 cycles in 1201 couples. J Reprod Infertil. 2012, 13:158-66.","journal-title":"J Reprod Infertil"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.07.003","article-title":"Effect of body mass index on intrauterine insemination cycle success","volume":"115","author":"Whynott RM","year":"2021","unstructured":"Whynott RM, Summers KM, Van Voorhis BJ, Mejia RB. Effect of body mass index on intrauterine insemination cycle success. Fertil Steril. 2021, 115:221-8. 10.1016\/j.fertnstert.2020.07.003","journal-title":"Fertil Steril"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082123","article-title":"Impact of BMI on fertility in an otherwise healthy population: a systematic review and meta-analysis","volume":"14","author":"Turner F","year":"2024","unstructured":"Turner F, Powell SG, Al-Lamee H, et al.. Impact of BMI on fertility in an otherwise healthy population: a systematic review and meta-analysis. BMJ Open. 2024, 14:e082123. 10.1136\/bmjopen-2023-082123","journal-title":"BMJ Open"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.12.037","article-title":"The Appraisal of Body Content (ABC) trial: increased male or female adiposity does not significantly impact in\u00a0vitro fertilization laboratory or clinical outcomes","volume":"116","author":"Kim J","year":"2021","unstructured":"Kim J, Patounakis G, Juneau C, et al.. The Appraisal of Body Content (ABC) trial: increased male or female adiposity does not significantly impact in\u00a0vitro fertilization laboratory or clinical outcomes. Fertil Steril. 2021, 116:444-52. 10.1016\/j.fertnstert.2020.12.037","journal-title":"Fertil Steril"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.09.139","article-title":"Female obesity increases the risk of miscarriage of euploid embryos","volume":"115","author":"Cozzolino M","year":"2021","unstructured":"Cozzolino M, Garc\u00eda-Velasco JA, Meseguer M, Pellicer A, Bellver J. Female obesity increases the risk of miscarriage of euploid embryos. Fertil Steril. 2021, 115:1495-502. 10.1016\/j.fertnstert.2020.09.139","journal-title":"Fertil Steril"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.01.019","article-title":"Overweight, obesity and assisted reproduction: a systematic review and meta-analysis","volume":"271","author":"Ribeiro LM","year":"2022","unstructured":"Ribeiro LM, Sasaki LM, Silva AA, Souza ES, Oliveira Lyrio A, Figueiredo A, Gottems LB. Overweight, obesity and assisted reproduction: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022, 271:117-27. 10.1016\/j.ejogrb.2022.01.019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.954428","article-title":"Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET","volume":"13","author":"Wu L","year":"2022","unstructured":"Wu L, Fang Q, Wang M, et al.. Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET. Front Endocrinol (Lausanne). 2022, 13:954428. 10.3389\/fendo.2022.954428","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56818-4","article-title":"Effect of weight loss before in vitro fertilization in women with obesity or overweight and infertility: a systematic review and meta-analysis","volume":"14","author":"Jeong HG","year":"2024","unstructured":"Jeong HG, Cho S, Ryu KJ, Kim T, Park H. Effect of weight loss before in vitro fertilization in women with obesity or overweight and infertility: a systematic review and meta-analysis. Sci Rep. 2024, 14:6153. 10.1038\/s41598-024-56818-4","journal-title":"Sci Rep"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey WT","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016, 22:1-203. 10.4158\/EP161365.GL","journal-title":"Endocr Pract"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-023-01120-7","article-title":"Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes","volume":"21","author":"Kotlyar AM","year":"2023","unstructured":"Kotlyar AM, Seifer DB. Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes. Reprod Biol Endocrinol. 2023, 21:70. 10.1186\/s12958-023-01120-7","journal-title":"Reprod Biol Endocrinol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-10-56","article-title":"The risk of adverse pregnancy outcomes in women who are overweight or obese","volume":"10","author":"Athukorala C","year":"2010","unstructured":"Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010, 10:56. 10.1186\/1471-2393-10-56","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19042063","article-title":"Predictors of adverse pregnancy outcomes in pregnant women living with obesity: a systematic review","volume":"19","author":"Fakhraei R","year":"2022","unstructured":"Fakhraei R, Denize K, Simon A, et al.. Predictors of adverse pregnancy outcomes in pregnant women living with obesity: a systematic review. Int J Environ Res Public Health. 2022, 19:2063. 10.3390\/ijerph19042063","journal-title":"Int J Environ Res Public Health"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.07.001","article-title":"Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review","volume":"118","author":"Vitek WS","year":"2022","unstructured":"Vitek WS, Hoeger KM. Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review. Fertil Steril. 2022, 118:447-55. 10.1016\/j.fertnstert.2022.07.001","journal-title":"Fertil Steril"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.09.019","article-title":"Obesity and the placenta: a consideration of nutrient exchange mechanisms in relation to aberrant fetal growth","volume":"32","author":"Higgins L","year":"2011","unstructured":"Higgins L, Greenwood SL, Wareing M, Sibley CP, Mills TA. Obesity and the placenta: a consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. Placenta. 2011, 32:1-7. 10.1016\/j.placenta.2010.09.019","journal-title":"Placenta"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20679","article-title":"Prepregnancy obesity: a complex risk factor for selected birth defects","volume":"88","author":"Carmichael SL","year":"2010","unstructured":"Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol. 2010, 88:804-10. 10.1002\/bdra.20679","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000043","article-title":"The effect of maternal obesity on the offspring","volume":"57","author":"Williams CB","year":"2014","unstructured":"Williams CB, Mackenzie KC, Gahagan S. The effect of maternal obesity on the offspring. Clin Obstet Gynecol. 2014, 57:508-15. 10.1097\/GRF.0000000000000043","journal-title":"Clin Obstet Gynecol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark AM","year":"1998","unstructured":"Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998, 13:1502-5. 10.1093\/humrep\/13.6.1502","journal-title":"Hum Reprod"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark AM","year":"1995","unstructured":"Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod. 1995, 10:2705-12. 10.1093\/oxfordjournals.humrep.a135772","journal-title":"Hum Reprod"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227766","article-title":"Effect of pregravid obesity on perinatal outcomes in singleton pregnancies following in vitro fertilization and the weight-loss goals to reduce the risks of poor pregnancy outcomes: a retrospective cohort study","volume":"15","author":"Liu L","year":"2020","unstructured":"Liu L, Wang H, Zhang Y, Niu J, Li Z, Tang R. Effect of pregravid obesity on perinatal outcomes in singleton pregnancies following in vitro fertilization and the weight-loss goals to reduce the risks of poor pregnancy outcomes: a retrospective cohort study. PLoS One. 2020, 15:e0227766. 10.1371\/journal.pone.0227766","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13532","article-title":"No effect of weight intervention on perinatal outcomes in obese women scheduled for in vitro fertilization treatment","volume":"98","author":"Einarsson S","year":"2019","unstructured":"Einarsson S, Bergh C, Kluge L, Thurin-Kjellberg A. No effect of weight intervention on perinatal outcomes in obese women scheduled for in vitro fertilization treatment. Acta Obstet Gynecol Scand. 2019, 98:708-14. 10.1111\/aogs.13532","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23371","article-title":"Benefits of weight loss of 10% or more in patients with overweight or obesity: a review","volume":"30","author":"Tahrani AA","year":"2022","unstructured":"Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: a review. Obesity (Silver Spring). 2022, 30:802-40. 10.1002\/oby.23371","journal-title":"Obesity (Silver Spring)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.06.004","article-title":"Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study","volume":"106","author":"Rothberg A","year":"2016","unstructured":"Rothberg A, Lanham M, Randolph J, Fowler C, Miller N, Smith Y. Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study. Fertil Steril. 2016, 106:1212-20. 10.1016\/j.fertnstert.2016.06.004","journal-title":"Fertil Steril"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2018-000387","article-title":"Women undergoing assisted fertilisation and high-intensity interval training: a pilot randomised controlled trial","volume":"4","author":"Kiel IA","year":"2018","unstructured":"Kiel IA, Lundgren KM, M\u00f8rkved S, Kj\u00f8tr\u00f8d SB, Salvesen \u00d8, Romundstad LB, Moholdt T. Women undergoing assisted fertilisation and high-intensity interval training: a pilot randomised controlled trial. BMJ Open Sport Exerc Med. 2018, 4:e000387. 10.1136\/bmjsem-2018-000387","journal-title":"BMJ Open Sport Exerc Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13804","article-title":"Association between preconception body mass index and fertility in adult female: a systematic review and meta-analysis","volume":"25","author":"Zhou J","year":"2024","unstructured":"Zhou J, Zhang Y, Teng Y, Dou L, Chen H, Tao F, Huang K. Association between preconception body mass index and fertility in adult female: a systematic review and meta-analysis. Obes Rev. 2024, 25:e13804. 10.1111\/obr.13804","journal-title":"Obes Rev"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01411-4","article-title":"Pathophysiology of obesity-related infertility and its prevention and treatment by potential phytotherapeutics","volume":"48","author":"Uddandrao VV","year":"2024","unstructured":"Uddandrao VV, Brahma Naidu P, Chandrasekaran P, Saravanan G. Pathophysiology of obesity-related infertility and its prevention and treatment by potential phytotherapeutics. Int J Obes (Lond). 2024, 48:147-65. 10.1038\/s41366-023-01411-4","journal-title":"Int J Obes (Lond)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.231","article-title":"Dietary fatty acid intakes and the risk of ovulatory infertility","volume":"85","author":"Chavarro JE","year":"2007","unstructured":"Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Dietary fatty acid intakes and the risk of ovulatory infertility. Am J Clin Nutr. 2007, 85:231-7. 10.1093\/ajcn\/85.1.231","journal-title":"Am J Clin Nutr"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.06.057","article-title":"Protein intake and ovulatory infertility","volume":"198","author":"Chavarro JE","year":"2008","unstructured":"Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Protein intake and ovulatory infertility. Am J Obstet Gynecol. 2008, 198:210-7. 10.1016\/j.ajog.2007.06.057","journal-title":"Am J Obstet Gynecol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz011","article-title":"Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis","volume":"25","author":"Sermondade N","year":"2019","unstructured":"Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, Fr\u00e9our T. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019, 25:439-51. 10.1093\/humupd\/dmz011","journal-title":"Hum Reprod Update"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64776-w","article-title":"Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis","volume":"10","author":"Kim CH","year":"2020","unstructured":"Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020, 10:7802. 10.1038\/s41598-020-64776-w","journal-title":"Sci Rep"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1327734","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth C","year":"2013","unstructured":"Seifarth C, Schehler B, Schneider HJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes. 2013, 121:27-31. 10.1055\/s-0032-1327734","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.06.026","article-title":"Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline","volume":"108","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2017","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril. 2017, 108:426-41. 10.1016\/j.fertnstert.2017.06.026","journal-title":"Fertil Steril"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s13669-023-00350-1","article-title":"Pharmacologic treatment of obesity in reproductive aged women","volume":"12","author":"Nuako A","year":"2023","unstructured":"Nuako A, Tu L, Reyes KJ, Chhabria SM, Stanford FC. Pharmacologic treatment of obesity in reproductive aged women. Curr Obstet Gynecol Rep. 2023, 12:138-46. 10.1007\/s13669-023-00350-1","journal-title":"Curr Obstet Gynecol Rep"},{"key":"ref77","article-title":"Naltrexone\/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults","volume":"41","author":"Sherman MM","year":"2016","unstructured":"Sherman MM, Ungureanu S, Rey JA. Naltrexone\/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults. P T. 2016, 41:164-72.","journal-title":"P T"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776795","article-title":"Navigating the role of anti-obesity agents prior to pregnancy: a narrative review","volume":"41","author":"Goldberg AS","year":"2023","unstructured":"Goldberg AS, Dolatabadi S, Dutton H, Benham JL. Navigating the role of anti-obesity agents prior to pregnancy: a narrative review. Semin Reprod Med. 2023, 41:108-18. 10.1055\/s-0043-1776795","journal-title":"Semin Reprod Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.2165\/11640860-000000000-00000","article-title":"Phentermine and topiramate extended release (Qsymia\u2122): first global approval","volume":"72","author":"Cameron F","year":"2012","unstructured":"Cameron F, Whiteside G, McKeage K. Phentermine and topiramate extended release (Qsymia\u2122): first global approval. Drugs. 2012, 72:2033-42. 10.2165\/11640860-000000000-00000","journal-title":"Drugs"},{"key":"ref80","article-title":"Reproductive toxic effects of Topamax ingestion in female Sprague-Dawley rats","volume":"26","author":"Khouri NA","year":"2005","unstructured":"Khouri NA. Reproductive toxic effects of Topamax ingestion in female Sprague-Dawley rats. Neuro Endocrinol Lett. 2005, 26:843-7.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0609","article-title":"A retrospective study examining phentermine on preconception weight loss and pregnancy outcomes","volume":"26","author":"Chang JJ","year":"2020","unstructured":"Chang JJ, Lathi RB, Kim SH. A retrospective study examining phentermine on preconception weight loss and pregnancy outcomes. Endocr Pract. 2020, 26:990-6. 10.4158\/EP-2019-0609","journal-title":"Endocr Pract"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson JS","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sj\u00f6str\u00f6m L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004, 27:155-61. 10.2337\/diacare.27.1.155","journal-title":"Diabetes Care"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003883","article-title":"Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial","volume":"19","author":"Legro RS","year":"2022","unstructured":"Legro RS, Hansen KR, Diamond MP, et al.. Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial. PLoS Med. 2022, 19:e1003883. 10.1371\/journal.pmed.1003883","journal-title":"PLoS Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard J","year":"2021","unstructured":"Ard J, Fitch A, Fruh S, Herman L. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther. 2021, 38:2821-39. 10.1007\/s12325-021-01710-0","journal-title":"Adv Ther"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310449","article-title":"Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials","volume":"24","author":"Popoviciu MS","year":"2023","unstructured":"Popoviciu MS, P\u0103duraru L, Yahya G, Metwally K, Cavalu S. Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials. Int J Mol Sci. 2023, 24:10449. 10.3390\/ijms241310449","journal-title":"Int J Mol Sci"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup A","year":"2009","unstructured":"Astrup A, Rossner S, Van Gaal L, et al.. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009, 374:1606-16. 10.1016\/S0140-6736(09)61375-1","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13225","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45","author":"Trujillo J","year":"2020","unstructured":"Trujillo J. Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. J Clin Pharm Ther. 2020, 45:43-60. 10.1111\/jcpt.13225","journal-title":"J Clin Pharm Ther"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0198-16.2016","article-title":"GLP-1R signaling directly activates arcuate nucleus kisspeptin action in brain slices but does not rescue luteinizing hormone inhibition in ovariectomized mice during negative energy balance","volume":"4","author":"Heppner KM","year":"2017","unstructured":"Heppner KM, Baquero AF, Bennett CM, et al.. GLP-1R signaling directly activates arcuate nucleus kisspeptin action in brain slices but does not rescue luteinizing hormone inhibition in ovariectomized mice during negative energy balance. eNeuro. 2017, 4:1-13. 10.1523\/ENEURO.0198-16.2016","journal-title":"eNeuro"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats","volume":"156","author":"Outeiri\u00f1o-Iglesias V","year":"2015","unstructured":"Outeiri\u00f1o-Iglesias V, Roman\u00ed-P\u00e9rez M, Gonz\u00e1lez-Mat\u00edas LC, Vigo E, Mallo F. GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats. Endocrinology. 2015, 156:4226-37. 10.1210\/en.2014-1978","journal-title":"Endocrinology"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121736","article-title":"Evidence for involvement of GIP and GLP-1 receptors and the gut-gonadal axis in regulating female reproductive function in mice","volume":"12","author":"Khan D","year":"2022","unstructured":"Khan D, Ojo OO, Woodward OR, et al.. Evidence for involvement of GIP and GLP-1 receptors and the gut-gonadal axis in regulating female reproductive function in mice. Biomolecules. 2022, 12:1736. 10.3390\/biom12121736","journal-title":"Biomolecules"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.03.023","article-title":"Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial","volume":"35","author":"Nylander M","year":"2017","unstructured":"Nylander M, Fr\u00f8ssing S, Clausen HV, Kistorp C, Faber J, Skouby SO. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online. 2017, 35:121-7. 10.1016\/j.rbmo.2017.03.023","journal-title":"Reprod Biomed Online"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4476","article-title":"Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice","volume":"35","author":"Zhang Y","year":"2016","unstructured":"Zhang Y, Xu F, Liang H, Cai M, Wen X, Li X, Weng J. Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice. Oncol Rep. 2016, 35:1340-8. 10.3892\/or.2015.4476","journal-title":"Oncol Rep"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084334","article-title":"The role of GLP-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome","volume":"23","author":"Bednarz K","year":"2022","unstructured":"Bednarz K, Kowalczyk K, Cwynar M, et al.. The role of GLP-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci. 2022, 23:4334. 10.3390\/ijms23084334","journal-title":"Int J Mol Sci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31271-1","article-title":"Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial","volume":"394","author":"Pratley R","year":"2019","unstructured":"Pratley R, Amod A, Hoff ST, et al.. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet. 2019, 394:39-50. 10.1016\/S0140-6736(19)31271-1","journal-title":"Lancet"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas JP","year":"2021","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, et al.. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021, 385:503-15. 10.1056\/NEJMoa2107519","journal-title":"N Engl J Med"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever M","year":"2014","unstructured":"Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Eur J Endocrinol. 2014, 170:451-9. 10.1530\/EJE-13-0797","journal-title":"Eur J Endocrinol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch K","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008, 93:2670-8. 10.1210\/jc.2008-0115","journal-title":"J Clin Endocrinol Metab"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185921","article-title":"Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs","volume":"12","author":"Carmina E","year":"2023","unstructured":"Carmina E, Longo RA. Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs. J Clin Med. 2023, 12:5921. 10.3390\/jcm12185921","journal-title":"J Clin Med"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144575","article-title":"The potential utility of tirzepatide for the management of polycystic ovary syndrome","volume":"12","author":"Anala AD","year":"2023","unstructured":"Anala AD, Saifudeen IS, Ibrahim M, Nanda M, Naaz N, Atkin SL. The potential utility of tirzepatide for the management of polycystic ovary syndrome. J Clin Med. 2023, 12:4575. 10.3390\/jcm12144575","journal-title":"J Clin Med"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"Salamun V","year":"2018","unstructured":"Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol. 2018, 179:1-11. 10.1530\/EJE-18-0175","journal-title":"Eur J Endocrinol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0668-z","article-title":"Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist","volume":"57","author":"Hall S","year":"2018","unstructured":"Hall S, Isaacs D, Clements JN. Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist. Clin Pharmacokinet. 2018, 57:1529-38. 10.1007\/s40262-018-0668-z","journal-title":"Clin Pharmacokinet"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta CE","year":"2024","unstructured":"Cesta CE, Rotem R, Bateman BT, et al.. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024, 184:144-52. 10.1001\/jamainternmed.2023.6663","journal-title":"JAMA Intern Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44644","article-title":"A case report of a pregnant woman with type 2 diabetes mellitus using dulaglutide during the first trimester of pregnancy","volume":"15","author":"Alghamdi A","year":"2023","unstructured":"Alghamdi A, Alsaeddi A, Malki H, Alsaedi A. A case report of a pregnant woman with type 2 diabetes mellitus using dulaglutide during the first trimester of pregnancy. Cureus. 2023, 15:e44644. 10.7759\/cureus.44644","journal-title":"Cureus"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12726","article-title":"Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with type 2 diabetes","volume":"32","author":"Greco D","year":"2015","unstructured":"Greco D. Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with type 2 diabetes. Diabet Med. 2015, 32:e29-30. 10.1111\/dme.12726","journal-title":"Diabet Med"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02331-z","article-title":"Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy","volume":"61","author":"Molteni M","year":"2024","unstructured":"Molteni M, Lodigiani S, Teliti M, Rotondi M, Guazzoni V. Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. Acta Diabetol. 2024, 61:1491-4. 10.1007\/s00592-024-02331-z","journal-title":"Acta Diabetol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78193","article-title":"Unmasking euglycemic diabetic ketoacidosis: the interplay of pregnancy, sepsis, and glucagon-like peptide 1 analog","volume":"17","author":"Huang A","year":"2025","unstructured":"Huang A, Lu J, Pancotto N, Sekhon GS, Gossen IM, Reyes JM, Lazarescu R. Unmasking euglycemic diabetic ketoacidosis: the interplay of pregnancy, sepsis, and glucagon-like peptide 1 analog. Cureus. 2025, 17:e78193. 10.7759\/cureus.78193","journal-title":"Cureus"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2023.10.037","article-title":"The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception","volume":"64","author":"Skelley JW","year":"2024","unstructured":"Skelley JW, Swearengin K, York AL, Glover LH. The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception. J Am Pharm Assoc (2003). 2024, 64:204-11. 10.1016\/j.japh.2023.10.037","journal-title":"J Am Pharm Assoc (2003)"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2022.02.050","article-title":"Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study","volume":"96","author":"Alqahtani AR","year":"2022","unstructured":"Alqahtani AR, Elahmedi M, Aldarwish A, Abdurabu HY, Alqahtani S. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study. Gastrointest Endosc. 2022, 96:44-50. 10.1016\/j.gie.2022.02.050","journal-title":"Gastrointest Endosc"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00538-5","article-title":"Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial","volume":"403","author":"Samarasinghe SNS","year":"2024","unstructured":"Samarasinghe SNS, Leca B, Alabdulkader S, et al.. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial. Lancet. 2024, 403:2489-503. 10.1016\/S0140-6736(24)00538-5","journal-title":"Lancet"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04900-3","article-title":"The impact of bariatric surgery compared to metformin therapy on pregnancy outcomes in patients with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"25","author":"Chang C","year":"2021","unstructured":"Chang C, Chang S, Poles J, Popov V. The impact of bariatric surgery compared to metformin therapy on pregnancy outcomes in patients with polycystic ovarian syndrome: a systematic review and meta-analysis. J Gastrointest Surg. 2021, 25:378-86. 10.1007\/s11605-020-04900-3","journal-title":"J Gastrointest Surg"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1381\/096089206778870148","article-title":"The impact of bariatric surgery on menstrual patterns","volume":"16","author":"Teitelman M","year":"2006","unstructured":"Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006, 16:1457-63. 10.1381\/096089206778870148","journal-title":"Obes Surg"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2012.12.010","article-title":"Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery","volume":"9","author":"Mechanick JI","year":"2013","unstructured":"Mechanick JI, Youdim A, Jones DB, et al.. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013, 9:159-91. 10.1016\/j.soard.2012.12.010","journal-title":"Surg Obes Relat Dis"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22719","article-title":"Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, the Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists","volume":"28","author":"Mechanick JI","year":"2020","unstructured":"Mechanick JI, Apovian C, Brethauer S, et al.. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, the Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020, 28:1-58. 10.1002\/oby.22719","journal-title":"Obesity (Silver Spring)"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede HJ","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJ, et al.. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023, 108:2447-69. 10.1210\/clinem\/dgad463","journal-title":"J Clin Endocrinol Metab"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-022-06134-5","article-title":"The influence of laparoscopic sleeve gastrectomy on pregnancy, delivery, and infant: does timing of pregnancy following laparoscopic sleeve gastrectomy affect outcomes?","volume":"32","author":"Froylich D","year":"2022","unstructured":"Froylich D, Loberman N, Cohen P, Lavie O, Hazzan D. The influence of laparoscopic sleeve gastrectomy on pregnancy, delivery, and infant: does timing of pregnancy following laparoscopic sleeve gastrectomy affect outcomes?. Obes Surg. 2022, 32:2567-71. 10.1007\/s11695-022-06134-5","journal-title":"Obes Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/368520-obesity-epidemic-and-its-impact-on-female-fertility-current-understanding-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T09:27:39Z","timestamp":1751621259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/368520-obesity-epidemic-and-its-impact-on-female-fertility-current-understanding-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":115,"URL":"https:\/\/doi.org\/10.7759\/cureus.87283","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}